Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Kidney Biopsy Market Size And Revenue Forecast Through 2030

The kidney biopsy sector has witnessed robust expansion lately, projecting an increase from $2.26 billion in 2025 to $2.38 billion in 2026, fueled by a compound annual growth rate of 5.4%. This historical upswing is attributable to a confluence of factors, including the escalating prevalence of chronic kidney disease, a rise in the incidence of glomerulonephritis and nephrotic syndrome, the continued diagnostic importance of renal biopsies in clinical practice, a growing number of kidney transplantations, and the proliferation of tertiary care facilities.

The market for kidney biopsies is projected for consistent expansion over the upcoming years, reaching an estimated $2.86 billion by 2030, fueled by a compound annual growth rate of 4.7%. This anticipated expansion during the forecast period is largely attributable to the escalating prevalence of kidney issues linked to diabetes, the increasing acceptance of biopsy procedures guided by ultrasound and CT scans, a heightened need for prompt identification of kidney ailments, ongoing progress in imaging technologies, and broader availability of expert nephrology services. Key developments expected within this timeframe include a stronger inclination towards less invasive kidney biopsy methods, a greater utilization of percutaneous biopsies performed under image guidance, a growing requirement for precise diagnosis of kidney conditions, the wider application of biopsy procedures for monitoring transplanted kidneys, and enhancements in the safety and accuracy of renal tissue acquisition.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16458&type=smp

Kidney Biopsy Market Expansion Supported By Key Demand Factors

The increasing occurrence of kidney cancer is anticipated to be a primary driver for the kidney biopsy market’s expansion. This type of cancer, marked by the aberrant proliferation of kidney cells, is becoming more prevalent due to elements like altered lifestyles, exposure to environmental contaminants, and enhanced diagnostic capabilities leading to a greater number of identified cases. Kidney biopsies are instrumental in the diagnosis and management of renal cancer, serving to verify malignant cells, establish a cancer’s stage, inform treatment strategies, track therapeutic efficacy, and offer insights into potential outcomes. For example, Cancer Research UK projects that new diagnoses of kidney cancer in the UK will climb from roughly 16,300 in 2023 to an estimated 21,900 by 2025, underscoring how the escalating rates of renal cancer are fueling the growth trajectory of the kidney biopsy market.

Kidney Biopsy Market Segment Analysis Highlighting Growth Areas

The kidney biopsy market covered in this report is segmented –

1) By Type: Percutaneous Biopsy, Surgical Biopsy

2) By Indication: Kidney Failure, Kidney Transplant, Hematuria, Proteinuria

3) By End-User: Hospitals And Clinics, Tertiary Care Centers, Other End-Users

Subsegments:

1) By Percutaneous Biopsy: Ultrasound-Guided Biopsy, CT-Guided Biopsy

2) By Surgical Biopsy: Open Kidney Biopsy, Laparoscopic Kidney Biopsy

Kidney Biopsy Market Growth Trends Influencing Competitive Dynamics

Leading entities within the kidney biopsy sector are actively engaged in creating cutting-edge systems by incorporating artificial intelligence (AI) to elevate diagnostic precision, optimize clinical workflows, and ultimately improve patient prognoses. The integration of AI offers a significant advantage to kidney biopsy procedures by refining image interpretation, furnishing diagnostic assistance, facilitating therapy design, delivering prognostic insights, and propelling kidney disease research forward. As a recent illustration, during March of 2024, Aiosyn, a software firm headquartered in the Netherlands, introduced its NephroPath platform. This NephroPath platform leverages advanced computational pathology algorithms designed to scrutinize histological markers present in kidney tissue samples, encompassing functions such as identifying distinct tissue classifications, quantifying interstitial fibrosis, and meticulously enumerating and evaluating glomeruli. Such AI-powered examination guarantees a uniform, thorough, and reliably repeatable evaluation of renal pathology indicators, thereby circumventing the limitations inherent in conventional scoring techniques and the variability introduced by individual observer interpretation.

Kidney Biopsy Market Leading Companies: Who Holds Significant Market Presence?

Major companies operating in the kidney biopsy market are Cardinal Health, Medtronic plc, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, Olympus Corporation, Hitachi Ltd., Canon Medical Systems Corporation, Cook Medical, B. Braun Melsungen AG, Merit Medical Systems Inc., Argon Medical Devices Inc., Stryker Corporation, Integra LifeSciences Corporation, Leica Biosystems, Hologic Inc., Samsung Medison Co. Ltd., Mindray Medical International Limited, Terumo Corporation, Fujifilm Holdings Corporation

Access The Complete Kidney Biopsy Market Report:

https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

Kidney Biopsy Market Largest Region: Which Geography Holds The Highest Market Share?

North Americawas the largest region in the kidney biopsy market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the kidney biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model